The development of a [211at]-astatinated endoradiotherapeutic drug: Part I. Localization by α-particle autoradiography in a murine tumor model
- 1 January 1992
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 23 (3) , 563-572
- https://doi.org/10.1016/0360-3016(92)90012-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Astatine-211: Its possible applications in cancer therapyInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986
- Biodistribution of 6-[211At]astato-2-methyl-1,4-naphthoquinol bis(diphosphate salt) and 211At− in mice with a transplanted rectal adenocarcinomaThe International Journal of Applied Radiation and Isotopes, 1984
- The in vitro selective concentration of an 125I-iodinated compound in human tumor cellsInternational Journal of Radiation Oncology*Biology*Physics, 1983
- A cell line from an induced carcinoma of mouse rectumThe Journal of Pathology, 1978
- Decays of,, andPhysical Review C, 1975
- Investigation of a Radioactive Drug (TRA 119) With Special Reference to Autoradiographic and Related StudiesActa Radiologica: Therapy, Physics, Biology, 1963
- Laboratory and Clinical Studies of Some Quinol Diphosphates and Related Compounds as Chemical Radiosensitizers and the Development of a Radioactive Drug (Part 1 of 4)Chemotherapy, 1961
- Clinical and Laboratory Studies of the Therapeutic Possibilities of Tritiated Synkavit, Mainly by Intra-Arterial AdministrationActa Radiologica, 1959
- Tracer Studies of Potential Radiosensitizing AgentsBritish Journal of Cancer, 1956
- THE ACCUMULATION AND DESTRUCTIVE ACTION OF ASTATINE211(EKA-IODINE) IN THE THYROID GLAND OF RATS AND MONKEYS*†Journal of Clinical Endocrinology & Metabolism, 1954